Clariane (CLARI.PA) Stock Price

Clariane Price

Euronext·CLOSED
3.94EUR-0.02 (-0.46 %)
Market closed

Revenue has compounded at 16.6% per year over the past 19 years to 5.28 B EUR. Earnings per share have declined at 9.3% per year over the last 17 years. Clariane's net margin stands at -1.0%, down from 1.0% several years earlier. Clariane currently offers a dividend yield of about 6.34%. Analysts set a median price target of 4.64 EUR, implying 17.7% above the current price. Of 15 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 19% above its 52-week low.

Clariane stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Clariane over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Clariane stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Clariane's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Clariane Stock Price History
DateClariane Price
7/22/20263.94 EUR
7/20/20263.96 EUR
7/17/20264.01 EUR
7/16/20264.05 EUR
7/15/20264.05 EUR
7/14/20264.04 EUR
7/13/20264.00 EUR
7/10/20263.97 EUR
7/9/20264.04 EUR
7/8/20264.04 EUR
7/7/20264.10 EUR
7/6/20264.12 EUR
7/3/20264.24 EUR
7/2/20264.20 EUR
7/1/20264.18 EUR
6/30/20264.11 EUR
6/29/20264.10 EUR
6/26/20264.23 EUR
6/25/20264.25 EUR
6/24/20264.16 EUR
6/23/20264.10 EUR
6/22/20264.14 EUR
6/19/20264.13 EUR
6/18/20264.01 EUR
6/17/20264.02 EUR
6/16/20264.08 EUR
6/15/20264.15 EUR
6/12/20264.05 EUR
6/11/20264.02 EUR
6/10/20264.03 EUR
6/9/20264.05 EUR
6/8/20264.06 EUR
6/5/20264.02 EUR
6/4/20264.04 EUR
6/3/20264.00 EUR
6/2/20264.04 EUR
6/1/20264.15 EUR
5/29/20264.26 EUR
5/28/20264.20 EUR
5/27/20264.23 EUR
5/26/20264.27 EUR
5/25/20264.25 EUR
5/22/20264.10 EUR
5/21/20264.06 EUR
5/20/20264.14 EUR
5/19/20264.11 EUR
5/18/20264.12 EUR
5/15/20264.26 EUR
5/14/20264.35 EUR
5/13/20264.20 EUR
5/12/20264.13 EUR
5/11/20264.17 EUR
5/8/20264.29 EUR
5/7/20264.22 EUR
5/6/20264.23 EUR
5/5/20264.15 EUR
5/4/20263.98 EUR
4/30/20264.04 EUR
4/29/20264.02 EUR
4/28/20264.08 EUR
4/27/20264.10 EUR
4/24/20264.03 EUR
4/23/20263.81 EUR
4/22/20263.77 EUR
4/21/20263.74 EUR
4/20/20263.76 EUR
4/17/20263.85 EUR
4/16/20263.85 EUR
4/15/20263.76 EUR
4/14/20263.75 EUR
4/13/20263.66 EUR
4/10/20263.75 EUR
4/9/20263.76 EUR
4/8/20263.90 EUR
4/7/20263.82 EUR
4/2/20263.65 EUR
3/27/20263.37 EUR
3/26/20263.40 EUR
3/25/20263.45 EUR
3/24/20263.50 EUR
3/23/20263.65 EUR
3/20/20263.62 EUR
3/19/20263.70 EUR
3/18/20263.79 EUR
3/17/20263.77 EUR
3/16/20263.80 EUR
3/13/20263.76 EUR
3/12/20263.74 EUR
3/11/20263.78 EUR
3/10/20263.92 EUR
3/9/20263.83 EUR
3/6/20263.85 EUR
3/5/20263.84 EUR
3/4/20263.89 EUR
3/3/20263.87 EUR
3/2/20264.07 EUR
2/27/20264.07 EUR
2/26/20263.78 EUR
2/25/20263.74 EUR
2/24/20263.76 EUR
2/23/20263.94 EUR
2/20/20263.87 EUR
2/19/20263.79 EUR
2/18/20264.05 EUR
2/17/20264.01 EUR
2/16/20263.83 EUR
2/13/20263.87 EUR
2/12/20263.97 EUR
2/11/20263.94 EUR
2/10/20263.97 EUR
2/9/20263.97 EUR
2/6/20263.84 EUR
2/5/20263.91 EUR
2/4/20263.89 EUR
2/3/20263.84 EUR
2/2/20263.89 EUR
1/30/20263.81 EUR
1/29/20263.79 EUR
1/28/20263.97 EUR
1/27/20264.04 EUR
1/26/20263.98 EUR
1/23/20263.89 EUR
1/22/20263.96 EUR
1/21/20263.86 EUR
1/20/20263.87 EUR
1/19/20263.85 EUR
1/16/20263.83 EUR
1/15/20263.93 EUR
1/14/20263.98 EUR
1/13/20263.81 EUR
1/12/20263.79 EUR
1/9/20263.88 EUR
1/8/20263.95 EUR
1/7/20263.87 EUR
1/6/20263.73 EUR
1/5/20263.81 EUR
1/2/20263.93 EUR
12/31/20253.93 EUR
12/30/20253.89 EUR
12/29/20253.83 EUR
12/24/20253.80 EUR
12/23/20253.85 EUR
12/22/20253.80 EUR
12/19/20253.74 EUR
12/18/20253.62 EUR
12/17/20253.62 EUR
12/16/20253.62 EUR
12/15/20253.59 EUR
12/12/20253.58 EUR
12/11/20253.68 EUR
12/10/20253.81 EUR
12/9/20253.77 EUR
12/8/20253.84 EUR
12/5/20253.76 EUR
12/4/20253.69 EUR
12/3/20253.84 EUR
12/2/20253.83 EUR
12/1/20253.75 EUR
11/28/20253.73 EUR
11/27/20253.67 EUR
11/26/20253.58 EUR
11/25/20253.54 EUR
11/24/20253.46 EUR
11/21/20253.32 EUR
11/20/20253.34 EUR
11/19/20253.39 EUR
11/18/20253.33 EUR
11/17/20253.34 EUR
11/14/20253.40 EUR
11/13/20253.46 EUR
11/12/20253.43 EUR
11/11/20253.42 EUR
11/10/20253.44 EUR
11/7/20253.33 EUR
11/6/20253.42 EUR
11/5/20253.46 EUR
11/4/20253.51 EUR
11/3/20253.53 EUR
10/31/20253.73 EUR
10/30/20253.75 EUR
10/29/20254.00 EUR
10/28/20253.92 EUR
10/27/20254.49 EUR
10/24/20254.50 EUR
10/23/20254.34 EUR
10/22/20254.20 EUR
10/21/20254.23 EUR
10/20/20254.34 EUR
10/17/20254.42 EUR
10/16/20254.45 EUR
10/15/20254.56 EUR
10/14/20254.65 EUR
10/13/20254.60 EUR
10/10/20254.51 EUR
10/9/20254.68 EUR
10/8/20254.50 EUR
10/7/20254.42 EUR
10/6/20254.48 EUR
10/3/20254.64 EUR
10/2/20254.72 EUR
10/1/20254.74 EUR
9/30/20254.73 EUR
9/29/20254.44 EUR
9/26/20254.33 EUR
9/25/20254.28 EUR
9/24/20254.34 EUR
9/23/20254.20 EUR
9/22/20254.21 EUR
9/19/20254.32 EUR
9/18/20254.22 EUR
9/17/20254.20 EUR
9/16/20254.30 EUR
9/15/20254.36 EUR
9/12/20254.35 EUR
9/11/20254.26 EUR
9/10/20254.01 EUR
9/9/20253.96 EUR
9/8/20253.91 EUR
9/5/20253.96 EUR
9/4/20254.00 EUR
9/3/20253.97 EUR
9/2/20254.00 EUR
9/1/20254.14 EUR
8/29/20254.28 EUR
8/28/20254.31 EUR
8/27/20254.41 EUR
8/26/20254.44 EUR
8/25/20254.63 EUR
8/22/20254.85 EUR
8/21/20254.77 EUR
8/20/20254.71 EUR
8/19/20254.70 EUR
8/18/20254.77 EUR
8/15/20254.63 EUR
8/14/20254.64 EUR
8/13/20254.53 EUR
8/12/20254.51 EUR
8/11/20254.52 EUR
8/8/20254.34 EUR
8/7/20254.47 EUR
8/6/20254.37 EUR
8/5/20254.36 EUR
8/4/20254.27 EUR
8/1/20254.43 EUR
7/31/20254.56 EUR
7/30/20254.40 EUR
7/29/20255.09 EUR
7/28/20255.06 EUR
7/25/20254.96 EUR
7/24/20254.69 EUR
Access this data via the Eulerpool API

Clariane Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
4.44 B EUR
334.40 M EUR
22.10 M EUR
Jan 1, 2023
5.00 B EUR
315.42 M EUR
-105.25 M EUR
Jan 1, 2024
5.28 B EUR
287.28 M EUR
-55.12 M EUR
Jan 1, 2025 (e)
5.54 B EUR
300.84 M EUR
-17.45 M EUR
Jan 1, 2026 (e)
5.76 B EUR
385.49 M EUR
92.48 M EUR
Jan 1, 2027 (e)
6.02 B EUR
447.80 M EUR
142.57 M EUR
Jan 1, 2028 (e)
6.15 B EUR
583.85 M EUR
169.29 M EUR
Jan 1, 2029 (e)
6.19 B EUR
630.62 M EUR
209.93 M EUR

Clariane Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 23, 2026, 7:48 AM
 
REVENUEB EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
DIV.EUR
DIV. GROWTH%
SHARESM
201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
2.222.572.983.133.333.613.774.144.445.005.285.545.766.026.156.19
63.8615.8015.865.006.498.374.439.687.2812.555.734.814.034.462.310.63
92.2191.7292.0591.9592.0592.3392.1392.5392.0791.9391.6991.6991.6991.6991.6991.69
2.052.362.742.883.073.343.483.834.094.594.845.075.285.515.645.68
188.00185.00242.00286.00307.00358.00286.00383.00334.00315.00287.00300.00385.00447.00583.00630.00
8.467.198.129.149.219.917.589.267.536.315.435.426.697.439.4710.17
61.0058.00131.00163.00123.00114.0039.0091.0022.00-105.00-55.00-17.0092.00142.00169.00209.00
117.86-4.92125.8624.43-24.54-7.32-65.79133.33-75.82-577.27-47.62-69.09-641.1854.3519.0123.67
0.300.600.600.600.600.600.300.350.250.250.250.25
-50.00100.0016.67-28.57
86.0086.0086.5090.7095.2096.30105.80105.30120.50170.59231.39231.39231.39231.39231.39231.39
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Clariane generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Clariane retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Clariane's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Clariane has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Clariane's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Clariane stock margins

The Clariane margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Clariane. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Clariane.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
92.13 %
7.58 %
1.04 %
Jan 1, 2021
92.52 %
9.27 %
2.20 %
Jan 1, 2022
92.07 %
7.53 %
0.50 %
Jan 1, 2023
91.93 %
6.31 %
-2.11 %
Jan 1, 2024
91.68 %
5.44 %
-1.04 %
Jan 1, 2025 (e)
91.68 %
5.44 %
-0.32 %
Jan 1, 2026 (e)
91.68 %
6.69 %
1.61 %
Jan 1, 2027 (e)
91.68 %
7.44 %
2.37 %

Clariane Stock Revenue, EBIT, Earnings per Share

The Clariane earnings per share therefore indicates how much revenue Clariane has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
35.66 EUR
2.70 EUR
0.37 EUR
Jan 1, 2021
39.29 EUR
3.64 EUR
0.87 EUR
Jan 1, 2022
36.83 EUR
2.78 EUR
0.18 EUR
Jan 1, 2023
29.28 EUR
1.85 EUR
-0.62 EUR
Jan 1, 2024
22.83 EUR
1.24 EUR
-0.24 EUR
Jan 1, 2025 (e)
15.52 EUR
1.30 EUR
-0.05 EUR
Jan 1, 2026 (e)
16.14 EUR
1.67 EUR
0.26 EUR
Jan 1, 2027 (e)
16.86 EUR
1.94 EUR
0.40 EUR

Clariane business model & stock analysis

Korian SA is a leading European provider of care and support services for elderly and dependent people. The company was founded in France in 2003 and operates over 810 facilities in eight countries, including France, Germany, Italy, Spain, Belgium, and the Netherlands. The company's business model is focused on providing appropriate solutions for every needy elderly person in any situation. Korian is divided into four main segments: long-term care, short-term care, assisted living, and psychiatric care. The company values the quality of care and support to ensure the highest possible standard of living for the individuals and their families. Korian offers a wide range of products and services, including care, support, catering, medical services, and targeted training for physical and mental fitness. The company develops innovative technologies to improve residents' living comfort and increase the efficiency of support services. Another important feature of Korian is its commitment to sustainability and corporate social responsibility, including environmentally friendly practices and protecting natural resources. Korian also strives to provide high-quality care and support tailored to the individual needs of older and dependent people. Long-term care is an important area of focus for Korian, as it caters to elderly people with various needs, including those with dementia, Alzheimer's, Parkinson's, or other illnesses. Korian ensures that these individuals have a comfortable and clinically appropriate environment to meet their needs. Short-term care is temporary support for the care needs of mostly younger people after surgeries or injuries. Korian offers a variety of options for short-term care to expedite the recovery process and promote independence. The assisted living segment offers older people the opportunity to live in a communal facility. Korian provides apartments with specific features such as private bathrooms or spacious kitchens. The communal facility offers comprehensive care and support with meals, laundry services, doctor visits, and social activities. Psychiatric care is another important sector in which Korian operates. This type of care is intended for people with mental health problems and includes support for those suffering from depression, anxiety, autism, or schizophrenia. Korian offers specialized psychiatric services such as outpatient therapies or inpatient treatments. In summary, Korian SA is a leading European provider of care and support services for elderly and dependent people. The company offers a wide range of products and services to ensure the highest possible standard of living for the individuals and their families. Korian strives to provide high-quality care and support tailored to the individual needs of each person.

Clariane SWOT Analysis

Strengths

  • Established brand presence in the global market.
  • Diverse product portfolio, including skincare, cosmetics, and fragrances.
  • Strong research and development capabilities, leading to innovative and high-quality products.

Weaknesses

  • Relatively higher prices compared to some competitors.
  • Overreliance on Asian market, limiting potential growth in other regions.
  • Lack of focus on sustainable and environmentally-friendly practices, which may pose risks in the long run.

Opportunities

  • Increasing demand for natural and organic beauty products, providing a chance for Korian SA to expand its offerings.
  • Growing e-commerce industry, enabling Korian SA to reach a wider customer base through online channels.
  • Potential for strategic partnerships or acquisitions to enhance market presence and diversify product range.

Threats

  • Intense competition from both established and emerging beauty brands.
  • Economic fluctuations and geopolitical issues, which may impact consumer purchasing power and demand for luxury beauty products.
  • Increasing regulations and consumer preferences towards cruelty-free and environmentally-friendly products, requiring adaptation of practices.

Clariane Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Clariane historical P/E ratio, EBIT multiple, and P/S ratio

Clariane annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Clariane shares outstanding

The number of shares of Clariane was 231.39 M in 2025. This indicates how many shares Clariane is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
105.80 M Stocks
Jan 1, 2021
105.30 M Stocks
Jan 1, 2022
120.50 M Stocks
Jan 1, 2023
170.59 M Stocks
Jan 1, 2024
231.39 M Stocks
Jan 1, 2025 (e)
231.39 M Stocks
Jan 1, 2026 (e)
231.39 M Stocks
Jan 1, 2027 (e)
231.39 M Stocks

Clariane Dividend History

16 years of dividend payments

YearAnnual DividendYoY ChangePayments
20230.25EUR 28.6%
20220.35EUR 16.7%
20210.30EUR 50.0%
20190.60EUR 0.0%
20180.60EUR 0.0%
20170.60EUR 0.0%
20160.60EUR 0.0%
20150.60EUR 100.0%
20140.30EUR 50.0%
20130.60EUR 0.0%

Clariane dividend history and estimates

In 2025, Clariane paid a dividend amounting to 0.25 EUR. Dividend means that Clariane distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
0.60 EUR
0.00 EUR
Jan 1, 2019
0.60 EUR
0.00 EUR
Jan 1, 2021
0.30 EUR
0.00 EUR
Jan 1, 2022
0.35 EUR
0.00 EUR
Jan 1, 2023
0.25 EUR
0.00 EUR
Jan 1, 2025 (e)
0.00 EUR
0.25 EUR
Jan 1, 2026 (e)
0.00 EUR
0.25 EUR
Jan 1, 2027 (e)
0.00 EUR
0.25 EUR

Clariane dividend payout ratio

In 2025, Clariane had a payout ratio of 112.14%. The payout ratio indicates the percentage of the company's profits that Clariane distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
91.97 %
Jan 1, 2021
34.88 %
Jan 1, 2022
194.44 %
Jan 1, 2023
-40.98 %
Jan 1, 2024
107.10 %
Jan 1, 2025 (e)
112.14 %
Jan 1, 2026 (e)
96.44 %
Jan 1, 2027 (e)
62.56 %

Current Clariane forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy73.33 % (11)
Hold20.00 % (3)
Sell6.67 % (1)
12M Price Target
4.64
Last Price
3.97
Currency
EUR
12M Return Potential
17.02 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Clariane stock

93/100
99
Environment
99
Social
80
Governance
E

Environment

20
Scope 1 - Direct Emissions74,844
Scope 2 - Indirect emissions from purchased energy50,721
Scope 3 - Indirect emissions within the value chain314,145
Total CO₂ emissions142,738.085
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees81
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Clariane shareholder structure

% Name
25.96921%
Crédit Agricole Assurances S.A.
Crédit Agricole Assurances S.A.
25.16645%
HLD Europe SCA
HLD Europe SCA
12.85150%
Flat Footed LLC
Flat Footed LLC
5.58957%
Holecek (M. Rene)
Holecek (M. Rene)
0.63732%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.45825%
JPMorgan Asset Management U.K. Limited
JPMorgan Asset Management U.K. Limited
...

Clariane Executives and Management Board

SB

Mrs. Sophie Boissard

(55)

Chief Executive Officer, Director, Member of the Management Board · since 2016

Compensation963,543.00 EUR
AL

Mrs. Anne Lalou

(61)

Independent Director

Compensation71,557.00 EUR
GB

Mr. Guillaume Bouhours

(49)

Independent Director

Compensation61,294.00 EUR
PL

Mr. Philippe Leveque

(65)

Independent Director

Compensation60,504.00 EUR
MM

Dr. Markus Mueschenich

(64)

Independent Director

Compensation47,126.00 EUR

Frequently asked questions about Clariane

Korian SA represents values of compassion, expertise, and innovation in the healthcare industry. As a leading company in Europe, Korian is committed to providing quality care and support to seniors and persons with disabilities. With a strong corporate philosophy of person-centered care, Korian focuses on promoting autonomy, well-being, and social integration for its residents. Through continuous research and development, they strive to deliver innovative solutions and services that meet the evolving needs of their customers. Korian SA's dedication to these values and corporate philosophy has established them as a trusted and respected healthcare provider in the market.

All fundamentals and in-depth analysis of Clariane

Our stock analysis for Clariane stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clariane. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.